Company: GVH
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004806
Chunk: 44

Company: Globavend Holdings Ltd
Filing Date: 2025-04-15
Form: DRS
Chunk 44
---
 Form 20-F beginning with our annual report for the fiscal year ending September 30, 2024. In addition, once we cease to be an “emerging growth company” as such term is defined in the JOBS Act, our independent registered public accounting firm must attest to and report on the effectiveness of our internal control over financial reporting. Our management may conclude that our internal control over financial reporting is not effective. Moreover, even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing, may issue an adverse report if it is not satisfied with our internal control or the level at which our control is documented, designed, operated, or reviewed, or if it interprets relevant requirements differently from us.

In addition, our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected.

Our Ordinary Shares are currently listed on Nasdaq. Nasdaq may delist our Ordinary Shares from trading, in which case the liquidity and market price of our Ordinary Shares could decline.

If
we fail to comply with the continued listing requirements to remain listed on Nasdaq, such as the Minimum Bid Price Requirement,
Nasdaq may delist our Ordinary Shares, we and our shareholders could face significant material adverse consequences, including:

| ● | A                                                                                                                                
 limited availability of market quotations for our Ordinary Shares;                                                               |
| ● | Reduced                                                                                                                          
 liquidity for our Ordinary Shares;                                                                                               |
| ● | A                                                                                                                                
 determination that our Ordinary Shares are “penny stock,” which would require brokers trading in our Ordinary Shares             
 to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for 
 our Ordinary Shares;                                                                                                             |
| ● | A                                                                                                                                
 limited amount of news about us and analyst coverage of us; and                                                                  |
| ● | A                                                                                                                                
 decreased ability for us to issue additional equity securities or obtain additional equity or debt financing in the future.      |

| 19 |

Because the amount, timing, and whether or not we distribute dividends at all is entirely at the discretion of our board of directors, you must rely on price appreciation